Back to Blog

The New Era of Weight Loss Management

April 27, 2026

Some medicines acting on appetite-related hormones can help eligible people manage obesity. They are not interchangeable, suitable for everyone or free of adverse effects.

Quick answer

Weight-management medicines can help eligible people, alongside appropriate care. They have product-specific risks and may require long-term review; regain after stopping is not simply a failure of willpower.

Prepare for the review appointment

  • Bring the exact medicine name and current prescription instructions.

  • Describe appetite changes, what you are eating and any troublesome symptoms.

  • Discuss a realistic follow-up schedule and how treatment success will be assessed.

  • Ask what the longer-term maintenance plan might involve.

Do not interpret a plateau or regain as a personal failure. Treatment decisions should account for health outcomes, tolerability, preferences and ongoing needs, rather than a single number on the scale.

What does the medicine do?

GLP-1 receptor agonists act on pathways involved in appetite and glucose regulation. A specific product must be assessed for its indication and risks. EMA’s Wegovy information describes semaglutide; it should not be used as the label for every medicine, or as evidence of UAE availability.

Compare the options: Read about oral weight-management medicine and how it differs from injections.

Why is follow-up important?

Discuss current medicines, relevant medical and family history, pregnancy plans and tolerability with the prescriber. Common digestive adverse effects and less common serious risks require product-specific advice. Do not change doses or combine weight-management products on your own.

What happens when treatment stops?

NIDDK notes that weight regain is likely after stopping medication. It should not be framed simply as a failure of willpower or proof that someone abandoned healthy habits. Review maintenance and treatment decisions with the clinical team.

How can nutrition care help?

Bring a record of appetite, meals and symptoms to follow-up. Discuss whether reduced intake is still meeting your needs and how to make meals manageable. A nutrition plan cannot guarantee that side effects, nutrient deficiencies or muscle loss will never occur.

Should I choose tablets or injections?

Compare the exact products with the prescriber. Route, effectiveness, contraindications, personal preferences and access all matter. The easiest format is not automatically the safest or best treatment.

General educational information; not a substitute for individual assessment, diagnosis or treatment.

Put it into practice: Explore nutrition counselling and coaching for sustainable everyday habits.

Frequently Asked Questions (FAQ)

Are all weight-management medicines interchangeable?

No. They differ in active ingredient, indications, dosing, risks and evidence. Advice must relate to the exact prescribed product.

Can weight return after medication stops?

Yes. NIDDK notes that regain is likely after stopping medication. It should not be described simply as a failure of willpower.

Can nutrition support guarantee no muscle loss or deficiencies?

No. A suitable plan and follow-up can support care, but cannot guarantee that side effects, deficiencies or muscle loss will never occur.

Should I change my dose if weight loss slows?

Do not change the dose or combine products on your own. Discuss progress, symptoms and longer-term goals with the prescriber.


Plan Your Nutrition and Follow-up

Discuss meals, appetite changes and realistic habits as part of coordinated care with your prescribing clinician.

Book a personalised nutrition consultation with Dr. Zeina


References

  1. European Medicines Agency — Wegovy: product overview and safety information

  2. NIDDK — Prescription Medications to Treat Overweight and Obesity

Book Now